Student or educator? Sign up with your school email and get 6 months of Pro free.
Cited by 168

The DOI matches its Crossref record.

A novel gene, MEL1, mapped to 1p36.3 is highly homologous to the MDS1/EVI1 gene and is transcriptionally activated in t(1;3)(p36;q21)-positive leukemia cells

Mochizuki, Naomi, Shimizu, Seiichi, Nagasawa, Toshiro, Tanaka, Hideo, Taniwaki, Masafumi, Yokota, Jun, Morishita, Kazuhiro·2000·Blood

Abstract

The reciprocal translocation t(1;3)(p36;q21) occurs in a subset of myelodysplastic syndrome (MDS) and acute myeloid leukemia (AML), which is frequently characterized by trilineage dysplasia, in particular dysmegakaryocytopoiesis, and poor prognosis. Previously, the breakpoint cluster region (BCR) at 3q21 was identified within a 60-kilobase (kb) region centromeric to the BCR of 3q21q26 syndrome and that at 1p36.3 within a 90-kb region. In this study, genes were searched near the breakpoints at 1p36.3, and a novel gene was isolated that encoded a zinc finger protein with a PR domain, which is highly homologous to theMDS1/EVI1 gene. The novel gene, designated asMEL1(MDS1/EVI1-like gene 1), with 1257 amino acid residues is 64% similar in nucleotide and 63% similar in amino acid sequences to MDS1/EVI1 with the same domain structure. The MEL1 gene is expressed in leukemia cells with t(1;3) but not in other cell lines or bone marrow, spleen, and fetal liver, suggesting that MEL1 is specifically in the t(1;3)(p36;q21)-positive MDS/AML. On the basis of the positional relationship between the EVI1 and MEL1 genes in each translocation, it was suggested that both genes are transcriptionally activated by the translocation of the 3q21 region with the Ribophorin I gene. Because of the transcriptional activation of the EVI1 family genes in both t(1;3)(p36;q21)-positive MDS/AML and 3q21q26 syndrome, it is suggested that they share a common molecular mechanism for the leukemogenic transformation of the cells.

Overview

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1182/blood.v96.9.3209

Cites

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

No references could be resolved yet.

Research works printed but not linked: 27

  1. Mitelman, 1997, A breakpoint map of recurrent chromosomal rearrangements in human neoplasia., Nat Genet., 15, 417, 10.1038/ng0497supp-417 · DOI · Paper page
  2. Secker-Walker, 1995, Abnormalities of 3q21 and 3q26 in myeloid malignancy: a United Kingdom Cancer Cytogenetic Group Study., Br J Haematol., 91, 490, 10.1111/j.1365-2141.1995.tb05329.x · doi:10.1111/j.1365-2141.1995.tb05329.x
  3. Testoni, 1999, 3q21 and 3q26 cytogenetic abnormalities in acute myeloblastic leukemia: biological and clinical features., Haematologica., 84, 690
  4. Morishita, 1992, Activation of EVI1 gene expression in human acute myelogenous leukemias by translocations spanning 300-400 kilobases on chromosome band 3q26., Proc Natl Acad Sci U S A., 89, 3937, 10.1073/pnas.89.9.3937 · DOI · Paper page
  5. Suzukawa, 1994, Identification of a breakpoint cluster region 3′ of the ribophorin I gene at 3q21 associated with the transcriptional activation of the EVI1 gene in acute myelogenous leukemias with inv(3)(q21q26)., Blood., 84, 2681, 10.1182/blood.V84.8.2681.2681 · DOI
  6. Suzukawa, 1997, Identification of translocational breakpoints within the intron region before the last coding exon (exon12) of the EVI1 gene in two cases of CML-BC with inv(3)(q21q26)., Genomics., 42, 356, 10.1006/geno.1997.4732 · doi:10.1006/geno.1997.4732
  7. Moir, 1984, A new translocation, t(1;3)(p36;q21), in myelodysplastic disorders., Blood., 64, 553, 10.1182/blood.V64.2.553.553 · DOI
  8. Bloomfield, 1985, t(1;3)(p36;q21) in acute nonlymphocytic leukemia: a new cytogenetic-clinicopathologic association., Blood., 66, 1409, 10.1182/blood.V66.6.1409.1409 · DOI
  9. Welborn, 1987, Diagnostic and prognostic significance of t(1;3)(p36;q21) in the disorders of hematopoiesis., Cancer Genet Cytogenet., 28, 277, 10.1016/0165-4608(87)90214-7 · doi:10.1016/0165-4608(87)90214-7
  10. Shimizu, 2000, Identification of breakpoint cluster regions at 1p36.3 and 3q21 in hematologic malignancies with t(1;3) (p36;q21)., Genes Chromosomes Cancer., 27, 229, 10.1002/(SICI)1098-2264(200003)27:3<229::AID-GCC2>3.0.CO;2-0 · doi:10.1002/(sici)1098-2264(200003)27:3<229::aid-gcc2>3.0.co;2-0
  11. Oval, 1990, Characterization of a factor-dependent acute leukemia cell line with translocation(3;3)(q21;q26)., Blood., 76, 1369, 10.1182/blood.V76.7.1369.1369 · doi:10.1182/blood.v76.7.1369.1369
  12. Asou, 1996, Establishment of an undifferentiated leukemia cell line (Kasumi-3) with t(3;7)(q27;q22) and activation of the EVI1 gene., Jpn J Cancer Res., 87, 269, 10.1111/j.1349-7006.1996.tb00216.x · doi:10.1111/j.1349-7006.1996.tb00216.x
  13. Gazdar, 1980, Mitogen requirements for the in vitro propagation of cutaneous T-cell lymphomas., Blood., 55, 409, 10.1182/blood.V55.3.409.409 · DOI · Paper page
  14. Minowada, 1972, Rosette-forming human lymphoid cell lines. I. Establishment and evidence for origin of thymus-derived lymphocytes., J Natl Cancer Inst., 49, 891
  15. Koeffler, 1978, Acute myelogenous leukemia: a human cell line responsive to colony-stimulating activity., Science., 200, 1153, 10.1126/science.306682 · DOI · Paper page
  16. Asou, 1996, Establishment of a myeloid leukaemia cell line (Kasumi-4) with t(9;22;11)(q34;q11;q13), inv(3)(q21q26) and the EVI1 gene activation from a patient with chronic myelogenous leukaemia in blast crisis., Br J Haematol., 93, 68, 10.1046/j.1365-2141.1996.4821023.x · doi:10.1046/j.1365-2141.1996.4821023.x
  17. Sato, 1989, Establishment of a human leukaemic cell line (CMK) with megakaryocytic characteristics from a Down's syndrome patient with acute megakaryoblastic leukaemia., Br J Haematol., 72, 184, 10.1111/j.1365-2141.1989.tb07681.x · doi:10.1111/j.1365-2141.1989.tb07681.x
  18. Ueda, 1996, Tumor-specific rearrangements of the immunoglobulin heavy-chain gene in B-cell non-Hodgkin's lymphoma detected by in situ hybridization., Blood., 87, 292, 10.1182/blood.V87.1.292.bloodjournal871292 · doi:10.1182/blood.v87.1.292.bloodjournal871292
  19. Akiyama, 1997, Isolation of a candidate gene, CAB1, for cholesterol transport to mitochondria from the c-ERBB-2 amplicon by a modified cDNA selection method., Cancer Res., 57, 3548
  20. Buyse, 1995, The retinoblastoma protein binds to RIZ, a zinc finger protein that shares an epitope with the adenovirus E1A protein., Proc Natl Acad Sci U S A., 92, 4467, 10.1073/pnas.92.10.4467 · DOI · Paper page
  21. Fears, 1997, Intergenic splicing of MDS1 and EVI1 occurs in normal tissues as well as in myeloid leukemia and produces a new member of the PR domain family., Proc Natl Acad Sci U S A., 93, 1642, 10.1073/pnas.93.4.1642 · DOI · Paper page
  22. Turner, 1998, Cloning and characterization of mCtBP2, a co-repressor that associated with basic Kruppel-like factor and other mammalian transcriptional regulators., EMBO J., 17, 5129, 10.1093/emboj/17.17.5129 · DOI · Paper page
  23. Pekarsky, 1997, Activation of a novel gene in 3q21 and identification of intergenic fusion transcripts with ecotropic viral insertion site I in leukemia., Cancer Res., 57, 3914
  24. Rajasekaran, 1995, Functional characterization of the cis-regulatory elements of the rat ribophorin I gene., Nucleic Acids Res., 23, 313, 10.1093/nar/23.3.313 · doi:10.1093/nar/23.3.313
  25. Huang, 1998, The PR domain of the Rb-binding zinc finger gene RIZ1 is a protein-binding interface and is related to the SET domain functioning in chromatin mediated gene expression., J Biol Chem., 273, 15933, 10.1074/jbc.273.26.15933 · DOI · Paper page
  26. Soderholm, 1997, The leukemia-associated gene MDS1/EVI1 is a new type of GATA-binding transactivator., Leukemia., 11, 352, 10.1038/sj.leu.2400584 · DOI
  27. Sood, 1999, MDS1/EVI1 enhances TGF-β1 signaling and strengthens its growth-inhibitory effect but the leukemia-associated fusion protein AML1/MDS1/EVI1, product of the t(3;21), abrogates growth-inhibition in response to TGF-β1., Leukemia., 13, 348, 10.1038/sj.leu.2401360 · doi:10.1038/sj.leu.2401360

Cited by

See all 168

Metadata

Authors
Mochizuki, N., Shimizu, S., Nagasawa, T., Tanaka, H., Taniwaki, M., Yokota, J., & Morishita, K.
Venue
Blood
Published
2000-11-01
Volume
96
Issue
9
Pages
3209-3214
ISSN
  • 0006-4971 (ISSN-L)
  • 1528-0020
OpenAlex
W1528295994
Cited by
168
References
0
FWCI
3.84
Type
journal article
Language
en
Open access
closed

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: A novel gene, MEL1, mapped to 1p36.3 is highly homologous to the MDS1/EVI1 gene and is transcriptionally activated in t(1;3)(p36;q21)-positive leukemia cells. https://app.cochat.ai/papers/10.1182/blood.v96.9.3209
The paper
Mochizuki, N., Shimizu, S., Nagasawa, T., Tanaka, H., Taniwaki, M., Yokota, J., & Morishita, K. (2000). A novel gene, MEL1, mapped to 1p36.3 is highly homologous to the MDS1/EVI1 gene and is transcriptionally activated in t(1;3)(p36;q21)-positive leukemia cells. Blood. https://doi.org/10.1182/blood.v96.9.3209

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.